Cargando…
Comparative Analysis of the Results of Stroke Treatment With Multiple Administrations of Wharton’s Jelly Mesenchymal Stem Cells–Derived HE-ATMP and Standard Conservative Treatment: Case Series Study
Stroke remains still the leading cause of long-term disability worldwide. Although interventions such as early reperfusion, intravenous thrombolysis, and endovascular revascularization have shown neurological benefit in stroke patients, there is still lack of effective treatment enabling regeneratio...
Autores principales: | Milczarek, Olga, Swadźba, Jakub, Swadźba, Patrycja, Starowicz-Filip, Anna, Krzyżewski, Roger M., Kwiatkowski, Stanisław, Majka, Marcin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10469225/ https://www.ncbi.nlm.nih.gov/pubmed/37644776 http://dx.doi.org/10.1177/09636897231195145 |
Ejemplares similares
-
Multiple Autologous Bone Marrow‐Derived CD271(+) Mesenchymal Stem Cell Transplantation Overcomes Drug‐Resistant Epilepsy in Children
por: Milczarek, Olga, et al.
Publicado: (2017) -
AFM-based Analysis of Wharton’s Jelly Mesenchymal Stem Cells
por: Szydlak, Renata, et al.
Publicado: (2019) -
The Treasury of Wharton's Jelly
por: Guenther, Rebecca, et al.
Publicado: (2021) -
Molecular and Functional Verification of Wharton’s Jelly Mesenchymal Stem Cells (WJ-MSCs) Pluripotency
por: Musiał-Wysocka, Aleksandra, et al.
Publicado: (2019) -
Regenerative Potential of the Product “CardioCell” Derived from the Wharton’s Jelly Mesenchymal Stem Cells for Treating Hindlimb Ischemia
por: Musiał-Wysocka, Aleksandra, et al.
Publicado: (2019)